Mangoceuticals, Inc. Debt Instrument, Convertible, Conversion Price
Mangoceuticals, Inc. (MGRX) had Debt Instrument, Convertible, Conversion Price of $1.50 per share as of 2025-01-27, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2026-08-13
- 2025-01-27: Debt Instrument, Convertible, Conversion Price $1.50.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2025-01-27 | $1.50 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |